Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | ||
| Net Income | -13,947 | -9,915 |
| Depreciation Amortization | 487 | 354 |
| Other Working Capital | 552 | 99 |
| Other Operating Activity | 479 | 0 |
| Operating Cash Flow | $-12,429 | $-9,462 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,758 | -409 |
| Sale Of Investment | N/A | 7,765 |
| Other Investing Activity | 20 | 9 |
| Investing Cash Flow | $-1,738 | $7,366 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 23 | 33 |
| Other Financing Activity | 21,356 | 0 |
| Financing Cash Flow | $21,379 | $33 |
| Beginning Cash Position | 20,016 | 22,079 |
| End Cash Position | 27,229 | 20,016 |
| Net Cash Flow | $7,213 | $-2,063 |
| Free Cash Flow | ||
| Operating Cash Flow | -12,429 | -9,462 |
| Capital Expenditure | -1,758 | -409 |
| Free Cash Flow | -14,186 | -9,870 |